(SLE)
BEXMARILIMAB(INNC)
IMMUNOGLOBULIN G4-KAPPA, ANTI-[HOMO SAPIENS STAB1 (STABILIN 1, STAB-1, CLEVER-1, FEEL-1, FELE-1, FEX1, SCARH2)], HUMANIZED MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HUMANIZED (1-449) [VH (HOMO SAPIENS IGHV2-5*09 (91.8%) -(IGHD) -IGHJ4*01 (100%)) [10.7.14] (1-122) -HOMO SAPIENS IGHG4*01, G4V5 H P10, G4V3 CH2 E1.2 (CH1 (123-220), HINGE 1- 12 S10>P (230)(221-232), CH2 L1.2>E (237) (233- 342), CH3 (343-447), CHS (448-449)) (123-449)], (136-215')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-215') [V-KAPPA (HOMO SAPIENS IGKV3-20*01 (80.2%) -IGKJ2*01 (100%)) [7.3.9] (1'-108') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (154), V101 (192) (109'-215')]; DIMER (228-228'':231-231'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA. PROPOSED INN: LIST 122; REC. INN LIST 84(WHO)
BEXMARILIMABUM(INN)